ULORIC can offer some key differences compared to allopurinol
*Based on results combined across three phase 3 studies ranging from 6-12 months; ULORIC 40 mg was only included in one of the studies, and ULORIC 80 mg and allopurinol were included in each of the studies.
Clinical studies comparing ULORIC and allopurinol for the treatment of gout found that
- 7 out of 10 gout patients taking ULORIC 80 mg reached a target uric acid level, less than
- As many patients on ULORIC 40 mg reached a healthy uric acid level as those on allopurinol
ULORIC offers some key differences in patients with mild to moderate kidney problems
- More patients with mild to moderate kidney problems reached a healthy uric acid level (less than
6 mg/dL) while taking ULORIC compared with allopurinol
- Unlike patients using allopurinol, patients with mild to moderate kidney problems do not have to change doses with ULORIC. The dose of ULORIC is limited to 40 mg once daily in patients with severe kidney problems.
ULORIC is not indicated to treat chronic kidney disease
If you have kidney problems, ask your healthcare professional about the differences between medicines used to lower uric acid levels.